Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Org Lett. 2022 Dec 9;24(48):8729-8734. doi: 10.1021/acs.orglett.2c02817. Epub 2022 Nov 29.
A copper-catalyzed protocol furnishing -arylated sulfoximines has been developed via dual N-H/C-H activation. Arylalkyl- and less reactive diarylsulfoximines were efficiently coupled with privileged scaffolds like indolines, indoles, and -Ar-7-azaindoles. Sulfoximines based on medicinally relevant scaffolds (phenothiazine, dibenzothiophene, thioxanthenone) were also well tolerated. Detailed mechanistic studies indicate that the deprotometalation and protodemetalation step is the reversible step.
一种铜催化的协议提供了 -芳基磺酰亚胺通过双重 N-H/C-H 激活。芳基烷基和反应性较低的二芳基磺酰亚胺与如吲哚啉、吲哚和 -Ar-7-氮杂吲哚等特权支架有效地偶联。基于药物相关支架的磺酰亚胺(吩噻嗪、二苯并噻吩、噻吨酮)也能很好地耐受。详细的机理研究表明,去金属化和原金属化步骤是可逆步骤。